Regulus Therapeutics said it has named Mary Glanville as its senior vice president of human capital and Christopher Aker as its senior director of legal affairs and secretary.
Glanville will be responsible for employee recruitment and retention, as well as aligning staff with the company's business needs. She joins Regulus from Anadys Pharmaceuticals where she led human resources.
Aker will handle all of Regulus' legal, corporate, and intellectual property matters, the company said. He previously served as corporate counsel and senior director of administration at Phenomix, a now shuttered drug developer.